Commonwealth Equity Services
CVS icon

Commonwealth Equity Services’s CVS Health CVS Stock Holding History

Commonwealth Equity Services’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.6M Sell
397,765
-35,089
-8% -$2.7M 0.04% 438
2025
Q4 		$34.4M Sell
432,854
-25,698
-6% -$2.03M 0.05% 375
2025
Q3 		$34.6M Buy
458,552
+15,357
+3% +$1.05M 0.04% 387
2025
Q2 		$30.6M Sell
443,195
-50,148
-10% -$3.29M 0.04% 431
2025
Q1 		$33.4M Sell
493,343
-17,579
-3% -$1.05M 0.05% 382
2024
Q4 		$22.9M Sell
510,922
-150,458
-23% -$8.44M 0.03% 484
2024
Q3 		$41.6M Sell
661,380
-44,632
-6% -$2.6M 0.06% 284
2024
Q2 		$41.7M Sell
706,012
-167,892
-19% -$10.5M 0.07% 280
2024
Q1 		$69.7M Sell
873,904
-23,124
-3% -$1.77M 0.12% 168
2023
Q4 		$70.8M Sell
897,028
-34,642
-4% -$2.47M 0.13% 154
2023
Q3 		$65M Sell
931,670
-44,271
-5% -$3.14M 0.13% 150
2023
Q2 		$67.5M Buy
975,941
+39,013
+4% +$2.78M 0.14% 148
2023
Q1 		$69.6K Buy
936,928
+44,919
+5% +$3.77M 0.15% 135
2022
Q4 		$83.1M Buy
892,009
+11,473
+1% +$1.11M 0.2% 107
2022
Q3 		$84M Buy
880,536
+17,961
+2% +$1.78M 0.22% 83
2022
Q2 		$79.9M Sell
862,575
-18,896
-2% -$1.84M 0.21% 95
2022
Q1 		$89.2M Sell
881,471
-28,776
-3% -$3.02M 0.2% 96
2021
Q4 		$93.9M Sell
910,247
-689
-0.1% -$63.7K 0.21% 94
2021
Q3 		$77.3M Buy
910,936
+45,050
+5% +$3.77M 0.19% 105
2021
Q2 		$72.2M Sell
865,886
-10,176
-1% -$833K 0.18% 114
2021
Q1 		$65.9M Buy
876,062
+25,695
+3% +$1.87M 0.19% 117
2020
Q4 		$58.1M Sell
850,367
-46,748
-5% -$3.04M 0.17% 123
2020
Q3 		$52.4M Buy
897,115
+34,645
+4% +$2.16M 0.18% 119
2020
Q2 		$56M Buy
862,470
+71,189
+9% +$4.48M 0.21% 98
2020
Q1 		$46.9M Buy
791,281
+39,838
+5% +$2.66M 0.22% 101
2019
Q4 		$55.8M Buy
751,443
+35,761
+5% +$2.51M 0.21% 100
2019
Q3 		$45.1M Buy
715,682
+37,826
+6% +$2.24M 0.19% 104
2019
Q2 		$36.9M Buy
677,856
+55,763
+9% +$3M 0.16% 129
2019
Q1 		$33.5M Buy
622,093
+104,734
+20% +$6.46M 0.15% 140
2018
Q4 		$33.9M Buy
517,359
+15,239
+3% +$1.14M 0.18% 120
2018
Q3 		$39.5M Buy
502,120
+49,814
+11% +$3.56M 0.19% 116
2018
Q2 		$29.1M Buy
452,306
+80,509
+22% +$5.31M 0.15% 129
2018
Q1 		$23.1M Buy
371,797
+10,039
+3% +$720K 0.13% 155
2017
Q4 		$26.2M Buy
361,758
+23,942
+7% +$1.74M 0.14% 145
2017
Q3 		$27.5M Sell
337,816
-26,644
-7% -$2.11M 0.16% 128
2017
Q2 		$29.3M Buy
364,460
+7,896
+2% +$623K 0.19% 116
2017
Q1 		$28M Buy
356,564
+61,919
+21% +$4.94M 0.19% 110
2016
Q4 		$23.3M Sell
294,645
-16,588
-5% -$1.34M 0.17% 123
2016
Q3 		$27.7M Buy
311,233
+5,950
+2% +$562K 0.22% 96
2016
Q2 		$29.2M Buy
305,283
+9,917
+3% +$988K 0.25% 85
2016
Q1 		$30.6M Buy
295,366
+4,268
+1% +$415K 0.27% 74
2015
Q4 		$28.5M Buy
291,098
+25,696
+10% +$2.52M 0.27% 77
2015
Q3 		$25.6M Buy
265,402
+6,562
+3% +$690K 0.27% 74
2015
Q2 		$27.1M Buy
258,840
+27,471
+12% +$2.81M 0.27% 75
2015
Q1 		$23.9M Buy
231,369
+3,035
+1% +$307K 0.25% 82
2014
Q4 		$22M Buy
228,334
+11,422
+5% +$1.01M 0.25% 87
2014
Q3 		$17.3M Buy
216,912
+9,255
+4% +$730K 0.21% 95
2014
Q2 		$15.7M Sell
207,657
-5,757
-3% -$435K 0.19% 106
2014
Q1 		$16M Sell
213,414
-6,228
-3% -$440K 0.22% 96
2013
Q4 		$15.7M Buy
219,642
+30,873
+16% +$1.98M 0.23% 92
2013
Q3 		$10.7M Buy
188,769
+20,931
+12% +$1.25M 0.17% 121
2013
Q2 		$9.6M Buy
+167,838
New +$9.72M 0.17% 125

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Commonwealth Equity Services's CVS Position: Q1 2026 in Review

Commonwealth Equity Services reduced its CVS Health (CVS) stake by 8.1% in Q1 2026, selling an estimated $2.7M and leaving 397,765 shares worth $28.6M. The position accounts for 0.04% of the portfolio, ranked #438.

Commonwealth Equity Services first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $93.9M in Q4 2021. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Commonwealth Equity Services held 397,765 shares of CVS Health worth $28.6M as of Q1 2026.
  • Commonwealth Equity Services sold 35,089 CVS Health shares in Q1 2026, an estimated $2.7M.
  • CVS Health made up 0.04% of Commonwealth Equity Services's portfolio in Q1 2026, its #438 holding.
  • Commonwealth Equity Services first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's CVS Health position peaked at $93.9M in Q4 2021.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.